Immuno Mycologics, Inc. 2003 Company Profile

01:30 EDT 24th June 2018 | BioPortfolio

The Company IMMY was founded in 1979 to produce fungal diagnostic products. IMMY then attracted a staff of knowledgable, qualified people who remain dedicated to quality and innovation. The company is located outside Norman, Oklahoma, the home of the University of Oklahoma, and the heartland of the United States.The Purpose The idea behind the founding of IMMY was that mycology was virtually a forgotten area in the clinical laboratory and diagnostic products for the mycoses would greatly benefit patients with mycotic infections. Initially, we concentrated on systemic mycoses (histoplasmosis, blastomycosis, coccidioidomycosis, and cryptococcosis). Subsequently, we have expanded the product line into the opportunistic and more esoteric fungi such as Aspergillus sp., Candida albicans, Paracoccidioides, etc


P.O.Box 1151
United States of America


Phone: 405-288-2383
Fax: 405-288-2228


News Articles [338 Associated News Articles listed on BioPortfolio]

10 Top Immuno-Oncology Companies

One of the most highly anticipated methods to fight cancer is the immuno-oncology (I/O) sector. For investors interested in the field the Investing News Network (INN) has put together a list of top im...

Immuno-PCR: A Highly Sensitive Method of Immunodetection

Researchers have relied on immunodetection techniques such as Western blotting, flow cytometry and Enzyme-Linked Immunosorbent Assay (ELISA) for years, but immuno-PCR is a relatively new method. By me...

Young Women’s ADHD Prescriptions Have Soared Since 2003, CDC Finds

(The Guardian) – Prescriptions for attention deficit hyperactivity disorder medications have increased 700% among US women in their late 20s since 2003, according to new research by the US Cente...

2003 to 2014 Saw Rise in Diabetic Ketoacidosis Admissions

TUESDAY, May 22, 2018 -- The incidence of hospitalization for diabetic ketoacidosis (DKA) and associated costs increased from 2003 to 2014, according to a study published online May 17 in Diabetes Car...

Phase II most common among immuno-oncology trials, 2008-2017

GlobalData has reviewed the phase of global clinical trials in the immuno-oncology (IO) space that were initiated between 2008 and...Read More... The post Phase II most common among immuno-oncology tr...

The Next Immuno-oncology Frontier?

Here’s some strong evidence for what could be the next wave of immuno-oncology: combining a TLR9 ligand with an OX40 antibody. We’re all going to have to get familiar with that sort of tal...

AbbVie Picks Up Dong-A Candidate As It Makes Immuno-Onc Inroads

Dong-A ST has scored a major early success in its inroads into cancer R&D through a sizable immuno-oncology deal with...  

Merck Boosts Immuno-oncology with Viralytics Buy

US drugmakerMerck & Co. has agreed to buy Australia’s Viralytics for $394 million, in a deal that will boost its immuno-oncology portfolio.

Drugs and Medications [32 Associated Drugs and Medications listed on BioPortfolio]

Penicillin v potassium [NorthStar Rx LLC]

Penicillin V Potassium Tablets, USP

Eco-clean elite [Ecolab Inc.]

Drug Facts

Boniva [Physicians Total Care, Inc.]

These highlights do not include all the information needed to use BONIVA Tablets safely and effectively. See full prescribing information for BONIVA Tablets. BONIVA® (ibandronate sodium) Tablets Init...

Boniva [Genentech, Inc.]

These highlights do not include all the information needed to use BONIVA Tablets safely and effectively. See full prescribing information for BONIVA Tablets. BONIVA (ibandronate sodium) Tablets Initia...

Bss [Alcon Laboratories, Inc.]

BSS® Sterile Irrigating Solution (balanced salt solution)

PubMed Articles [298 Associated PubMed Articles listed on BioPortfolio]

Point of Care Cryptococcal Antigen Screening: Pipetting Finger-Prick Blood Improves Performance of Immuno-Mycologics Lateral Flow Assay.

Cryptococcal antigen (CrAg) screening at point of care could improve cryptococcal meningitis prevention where laboratory resources are limited. We evaluated the accuracy of Immuno-Mycologics (IMMY, No...

Trends and Determinants of Comprehensive Knowledge of HIV among Adolescents and Young Adults in Nigeria: 2003 - 2013.

This study examined comprehensive knowledge of HIV (CKH) and its determinants among young people aged 15-24 years in Nigeria between 2003 and 2013. Secondary analysis was conducted on three rounds of ...

Minimal Information About an Immuno-Peptidomics Experiment (MIAIPE).

Minimal Information about an Immuno-Peptidomics Experiment (MIAIPE) is an initiative of the members of the Human Immuno-Peptidome Project (HIPP), an international program organized by the Human Proteo...

Rational design and identification of immuno-oncology drug combinations.

Clinical trials investigating immuno-oncology (IO) drug combinations are largely based on empiricism or limited non-clinical evaluations. This study identified the current combination IO drug clinical...

Cervical Adenocarcinoma: A Comparison of the Reproducibility of the World Health Organization 2003 and 2014 Classifications.

The aim of the study was to compare the reproducibility of malignant glandular tumors of the uterine cervix classified per World Health Organization (WHO) 2003 and 2014.

Clinical Trials [1128 Associated Clinical Trials listed on BioPortfolio]

Pilot Study To Assess CAT-2003 in Patients With Severe Hypertriglyceridemia

The purpose of this study is to determine the safety and efficacy of multiple doses of CAT-2003 in patients with severe hypertriglyceridemia either naive or refractory to current therapy. ...

Exposure Chamber Trial With Cat Immunotherapy

The main purpose of this trial is to investigate if any of three different doses of cat hair immunotherapy is safe for treatment of cat allergic patients.

Study of NPL-2003 in Adolescents With Obsessive Compulsive Disorder (OCD)

The purpose of this study is to investigate the effect of NPL-2003 on the symptoms of Obsessive Compulsive Disorder (OCD) in an adolescent population.

Reacto & Immunogenicity of TF Formulation of Influsplit SSW® 2002/03 v/s Std Formulation of Influsplit SSW® 2002/03

This is a comparative vaccination study of the reactogenicity and immunogenicity of a thiomersal-free formulation of Influsplit SSW® 2002/2003 versus the standard formulation of Influspli...

Compatibility and Immunogenicity of a Short Specific Immunotherapy (SIT) in Contrast to Classic Specific Immunotherapy

We wanted to examine the immunogenicity and safety of a shortened specific immunotherapy in contrast to the standard specific immunotherapy. Therefore, we challenged 12 patients for 14 we...

Companies [542 Associated Companies listed on BioPortfolio]

Immuno Mycologics, Inc. 2003

The Company IMMY was founded in 1979 to produce fungal diagnostic products. IMMY then attracted a staff of knowledgable, qualified people who remain dedicated to quality and innovation. The company i...

Bionor Immuno AS

Bionor Immuno is a multidisciplinary drug discovery company located in Skien, Norway. The major focus of the company is to develop effective peptide based immunotherapies, against infectious diseases ...

Immuno Laboratories

Headquartered in Fort Lauderdale, Florida, Immuno Laboratories is widely recognized as one of the leading food and environmental allergy testing facilities in the world. Since 197...

Immunotech Laboratories, Inc.

Headquartered in Monrovia, CA, Immunotech Laboratories is a drug development company committed to the commercialization of its proprietary proteins for the treatment of debilitati...


SDI is a leading healthcare market insight and analytics firm. It provides the industry’s most comprehensive de-identified patient-level data to pharmaceutical, biotech, reta...

More Information about "Immuno Mycologics, Inc. 2003" on BioPortfolio

We have published hundreds of Immuno Mycologics, Inc. 2003 news stories on BioPortfolio along with dozens of Immuno Mycologics, Inc. 2003 Clinical Trials and PubMed Articles about Immuno Mycologics, Inc. 2003 for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Immuno Mycologics, Inc. 2003 Companies in our database. You can also find out about relevant Immuno Mycologics, Inc. 2003 Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record